Minocycline as an Evidence-Based Adjunct Treatment in Schizophrenia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Minocycline, a tetracycline antibiotic, has been studied in multiple clinical trials for its potential effects on the symptoms of schizophrenia. This article reviews the evidence regarding minocycline's adjunctive use as reported in the published literature, and discusses its potential mechanism of action, safety, and tolerability profile. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Psychiatric Annals is the property of SLACK Incorporated and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)